Showing 1 to 10 of 13 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
CFXX489A12101 NCT06562192  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Breast Colon and Rectum Non Small Cells - Lung Pancreas |
Dr. Nicolas Plouznikoff Adeline Hamon 514-890-8000 poste 30737 |
|
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
MK-9999-02A NCT06428409 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Colon and Rectum Hepatic Ducts Pancreas |
Dr. Francine Aubin Adeline Hamon 514-890-8000 poste 30737 |
|
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
MK-9999-02A NCT06428409 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Colon and Rectum Hepatic Ducts Pancreas |
Dr. Victoria Mandilaras Rodrigo Skowronski 514-934-1934 poste 36275 |
|
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
PAC.3 (A021806) NCT04340141 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Pancreas |
Dr. Nicolas Marcoux Mélanie Croussette 418-525-4444 poste 22637 |
|
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX: a Prospective, Pilot Study
PDAC-LIV NCT06349278 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Pancreas |
Dr. Alexandre Brind’Amour Maryse Gingras 418-525-4444 poste 15781 |
|
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
AT-PANC-101 NCT04002479 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Pancreas |
Dr. Corey Miller Pricille Cleveaux 514-340-8222 poste 24480 |
|
Quebec Pancreas Cancer Study
QPCS NCT04104230 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Pancreas |
Dr. George Zogopoulos Adeline Cuggia 514-934-1934 poste 76333 |
|
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
PAC.3 (A021806) NCT04340141 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Pancreas |
Dr. Frédéric Lemay Michelle Roy 819-346-1110 poste 12848 |
|
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
PAC.3 (A021806) NCT04340141 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Pancreas |
Dr. George Zogopoulos Jacqueline Lewis 514-934-1934 poste 34909 |
|
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With Other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion
20230223 NCT06360354 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Hepatic Ducts Pancreas |
Dr. Maxime Chénard-Poirier Maryse Gingras 418-525-4444 poste 15781 |
Groupe d'étude en oncologie du Québec